Impact of HER2 status in resected gastric or gastroesophageal junction adenocarcinoma in a Western population

BACKGROUND: HER2 status is a predictive biomarker of response to trastuzumab in advanced gastric or gastroesophageal junction (GEJ) adenocarcinoma. However, there is relatively little known about the role of HER2 in resected gastric or GEJ adenocarcinoma in the Western population. METHODS: Retrospec...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Gepubliceerd in:Ecancermedicalscience
Hoofdauteurs: Lago, Nieves Martínez, Villar, María Vieito, Ponte, Rafael Varela, Nallib, Ihab Abdulkader, Alvarez, Juan José Carrera, López, José Ramón Antúnez, López, Rafael López, Iruegas, María Elena Padin
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: Cancer Intelligence 2020
Onderwerpen:
Research
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC7105341/
https://ncbi.nlm.nih.gov/pubmed/32256703
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3332/ecancer.2020.1020
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items